Tatva Chintan Pharma Chem Limited

TATVA

INE0GK401011

Specialty Chemicals

End-of-day quote NSE India S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
1,027 ^INR	+1.05%		-0.65%	-35.88%

03/05	Transcript : Tatva Chintan Pharma Chem Limited, Q4 2024 Earnings Call, May 03, 2024
03/05	Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2023-2024	CI

Tatva Chintan Pharma Chem Limited Announces Commencement of Commercial Production of New Facility At Dahej Manufacturing Plant

April 05, 2023 at 05:35 pm IST

Tatva Chintan Pharma Chem Limited announced that the Company has successfully commenced its commercial production from New Facility at Dahej Manufacturing plant situated at Plot No.: Z/103/F/1&2, SEZ Area, Part-2, Dahej, Bharuch, Gujarat - 392130 on 05 April 2023.

Latest news about Tatva Chintan Pharma Chem Limited

Transcript : Tatva Chintan Pharma Chem Limited, Q4 2024 Earnings Call, May 03, 2024	03/05
Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2023-2024	03/05	CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	03/05	CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Full Year Ended March 31, 2024	03/05	CI
Tatva Chintan Pharma Chem Limited Accords Environmental Clearance to for Setting Up Plant for Manufacturing of Chemicals	30/04	CI
Certain Equity Shares of Tatva Chintan Pharma Chem Limited are subject to a Lock-Up Agreement Ending on 25-FEB-2024.	25/02	CI
Transcript : Tatva Chintan Pharma Chem Limited, Q3 2024 Earnings Call, Jan 20, 2024	20/01
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	20/01	CI
Transcript : Tatva Chintan Pharma Chem Limited, Q2 2024 Earnings Call, Nov 02, 2023	02/11
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11	CI
Crisil Affirms A- Rating on Tatva Chintan Pharma Chem's Debt Financing; Outlook Stable	22/23/22	MT
Transcript : Tatva Chintan Pharma Chem Limited, Q1 2024 Earnings Call, Aug 04, 2023	04/23/04
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	04/23/04	CI
Tatva Chintan Pharma Chem's Consolidated Profit Shrinks in Fiscal Q4	08/23/08	MT
Transcript : Tatva Chintan Pharma Chem Limited, Q4 2023 Earnings Call, May 05, 2023	05/23/05
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Full Year Ended March 31, 2023	05/23/05	CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	05/23/05	CI
Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2022-23	05/23/05	CI
Tatva Chintan Pharma Chem Begins Commercial Production at New Unit in Dahej, India	06/23/06	MT
Tatva Chintan Pharma Chem Limited Announces Commencement of Commercial Production of New Facility At Dahej Manufacturing Plant	05/23/05	CI
Transcript : Tatva Chintan Pharma Chem Limited, Q3 2023 Earnings Call, Jan 24, 2023	24/23/24
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	24/23/24	CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	04/22/04	CI
Certain Equity Shares of Tatva Chintan Pharma Chem Limited are subject to a Lock-Up Agreement Ending on 26-JUL-2022.	26/22/26	CI

Chart Tatva Chintan Pharma Chem Limited

Duration

Period

More charts

Company Profile

Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of verity of chemicals include structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are quarternary salts, which helps in the formation of channels and pores during the synthesis of zeolites. Its PTCs are used to facilitate the migration of a reactant from one phase into another phase where the reaction occurs in a heterogeneous multi-phase system. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. The Company is focused on serving various customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavors and fragrances industries.

Sector

Specialty Chemicals

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Tatva Chintan Pharma Chem Limited

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,027 INR

Average target price

1,674 INR

Spread / Average Target

+63.02%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
TATVA CHINTAN PHARMA CHEM LIMITED	-35.88%	29Cr
ECOLAB INC.	+20.59%	6.83TCr
SIKA AG	-1.02%	4.85TCr
GIVAUDAN SA	+23.82%	4.44TCr
FUJIFILM HOLDINGS CORPORATION	+30.26%	2.83TCr
EMS-CHEMIE HOLDING AG	+7.56%	1.91TCr
SYMRISE AG	+10.55%	1.66TCr
CELANESE CORPORATION	-5.73%	1.6TCr
POSCO FUTURE M CO., LTD.	-21.45%	1.58TCr
ALBEMARLE CORPORATION	-20.45%	1.35TCr

Other Specialty Chemicals